Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index, and 1 are not checked yet.

The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype

Open access
Noguchi, Toshihiro, Katoh, Hiroyuki, Nomura, Satoshi, Okada, Keiko, Watanabe, Masahiko · 2024 · Frontiers in Neuroscience

Abstract

Although a wide variety of mechanisms take part in the secondary injury phase of spinal cord injury (SCI), inflammation is the most important factor implicated in the sequelae after SCI. Being central to the inflammation reaction, macrophages and their polarization are a topic that has garnered wide interest in the studies of SCI secondary injury. The glucagon-like peptide 1 (GLP-1) receptor agonist exenatide has been shown to enhance the endoplasmic reticulum stress response and improve motor function recovery after spinal cord injury (SCI). Since exenatide has also been reported to induce the production of M2 cells in models of cerebral infarction and neurodegenerative diseases, this study was conducted to examine the effects of exenatide administration on the inflammation process that ensues after spinal cord injury. In a rat contusion model of spinal cord injury, the exenatide group received a subcutaneous injection of 10 μg exenatide immediately after injury while those in the control group received 1 mL of phosphate-buffered saline. Quantitative RT-PCR and immunohistochemical staining were used to evaluate the effects of exenatide administration on the macrophages infiltrating the injured spinal cord, especially with regard to macrophage M1 and M2 profiles. The changes in hind limb motor function were assessed based on Basso, Beattie, Bresnahan locomotor rating scale (BBB scale) scores. The improvement in BBB scale scores was significantly higher in the exenatide group from day 7 after injury and onwards. Quantitative RT-PCR revealed an increase in the expression of M2 markers and anti-inflammatory interleukins in the exenatide group that was accompanied by a decrease in the expression of M1 markers and inflammatory cytokines. Immunohistochemical staining showed no significant difference in M1 macrophage numbers between the two groups, but a significantly higher number of M2 macrophages was observed in the exenatide group on day 3 after injury. Our findings suggest that exenatide administration promoted the number of M2-phenotype macrophages after SCI, which may have led to the observed improvement in hind limb motor function in a rat model of SCI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2024.1342944

Cites

93 of 94 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Change in BBB scale scores over time. BBB scale scores improved over time in both the exenatide and control groups, but there was significantly greater improvement in the exenatide group from day 7 after injury onwards. n = 5; error bars: SDs; *p < 0.05, **p < 0.01.
Figure 1 Change in BBB scale scores over time. BBB scale scores improved over time in both the exenatide and control groups, but there was significantly greater improvement in the exenatide group from day 7 after injury onwards. n = 5; error bars: SDs; *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 2 mRNA expression levels of M1 markers in the injured spinal cord. Compared to the control group, the exenatide group showed significantly lower iNOS mRNA levels on day 3 after injury (A), lower CD16 levels on day 1 after injury (B), and lower CD86 levels on day 3 after injury (C). β-actin was used as the control. n = 5; error bars: SDs; *p < 0.05, **p < 0.01.
Figure 2 mRNA expression levels of M1 markers in the injured spinal cord. Compared to the control group, the exenatide group showed significantly lower iNOS mRNA levels on day 3 after injury (A), lower CD16 levels on day 1 after injury (B), and lower CD86 levels on day 3 after injury (C). β-actin was used as the control. n = 5; error bars: SDs; *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 3 mRNA expression levels of M2 markers in the injured spinal cord. Compared to the control group, the exenatide group showed significantly higher Arginase 1 mRNA levels (A) and higher CD163 levels (B) on day 3 after injury, and significantly higher CD206 levels on days 1 and 3 after injury (C). β-actin was used as the control. n = 5; error bars: SDs; *p < 0.05, **p < 0.01.
Figure 3 mRNA expression levels of M2 markers in the injured spinal cord. Compared to the control group, the exenatide group showed significantly higher Arginase 1 mRNA levels (A) and higher CD163 levels (B) on day 3 after injury, and significantly higher CD206 levels on days 1 and 3 after injury (C). β-actin was used as the control. n = 5; error bars: SDs; *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 4 mRNA expression levels of various cytokines in SCI. Compared to the control group, the mRNA expression levels of pro-inflammatory cytokines were lower in the exenatide group, with TNFα significantly lower on days 1 and 3 after injury (A) and IL-1β significantly lower on day 1 after injury (B). Conversely, the mRNA expression levels of anti-inflammatory cytokines were higher in the exenatide group, with both IL-4 (C) and IL-10 (D) significantly higher on day 1 after injury. β-actin was used as the control; n = 5; error bars: SDs; *p < 0.05, **p < 0.01.
Figure 4 mRNA expression levels of various cytokines in SCI. Compared to the control group, the mRNA expression levels of pro-inflammatory cytokines were lower in the exenatide group, with TNFα significantly lower on days 1 and 3 after injury (A) and IL-1β significantly lower on day 1 after injury (B). Conversely, the mRNA expression levels of anti-inflammatory cytokines were higher in the exenatide group, with both IL-4 (C) and IL-10 (D) significantly higher on day 1 after injury. β-actin was used as the control; n = 5; error bars: SDs; *p < 0.05, **p < 0.01.CC BY · PubMed Central
Figure 5 M1 macrophages in the injured spinal cord. (A) Representative immunohistochemical staining results for the M1 profile. DAPI: blue, Iba1: red, iNOS: green. Scale bar: 10 μm. (B) The number of Iba1+ iNOS+ cells in the posterior funiculus showing no difference among exenatide and control groups. n = 5; error bar: SD.
Figure 5 M1 macrophages in the injured spinal cord. (A) Representative immunohistochemical staining results for the M1 profile. DAPI: blue, Iba1: red, iNOS: green. Scale bar: 10 μm. (B) The number of Iba1+ iNOS+ cells in the posterior funiculus showing no difference among exenatide and control groups. n = 5; error bar: SD.CC BY · PubMed Central
Figure 6 M2 macrophages in the injured spinal cord. (A) Representative immunohistochemical staining results for the M2 profile. DAPI: blue, Iba1: red, Arginase 1: green. Scale bar: 10 μm. (B) The number of Iba1+ Arginase 1+ cells in the posterior funiculus showing significantly higher numbers of M2 macrophages in the exenatide group on day 3 after injury. n = 5; error bar: SD; *p < 0.05.
Figure 6 M2 macrophages in the injured spinal cord. (A) Representative immunohistochemical staining results for the M2 profile. DAPI: blue, Iba1: red, Arginase 1: green. Scale bar: 10 μm. (B) The number of Iba1+ Arginase 1+ cells in the posterior funiculus showing significantly higher numbers of M2 macrophages in the exenatide group on day 3 after injury. n = 5; error bar: SD; *p < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 93 references

Cited by

See all 21

Metadata

Authors
Noguchi, T., Katoh, H., Nomura, S., Okada, K., & Watanabe, M.
Affiliations
Tokai University (JP)
Corresponding author
Katoh, Hiroyuki
Venue
Frontiers in Neuroscience
Published
2024-02-15
Volume
18
Pages
1342944-1342944
ISSN
1662-453X (ISSN-L)
OpenAlex
W4391838285
Cited by
20
References
93
Citations by year
2026: 10 · 2025: 7 · 2024: 3
FWCI
6.04
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
JSPS
Topics
  • Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
exenatide, spinal cord injury, macrophage polarization, M2 macrophages, M1 macrophages, GLP-1 receptor agonists, neuroinflammation, secondary injury, bruising, anti-inflammatory cytokines, endoplasmic reticulum stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype. https://app.cochat.ai/papers/10.3389/fnins.2024.1342944
The paper
Noguchi, T., Katoh, H., Nomura, S., Okada, K., & Watanabe, M. (2024). The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1342944

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.